These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 23600605

  • 21. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Suresh M, Nithya N, Jayasree PR, Vimal KP, Manish Kumar PR.
    World J Microbiol Biotechnol; 2018 May 30; 34(6):83. PubMed ID: 29846800
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.
    Pathol Biol (Paris); 2009 May 30; 57(7-8):530-5. PubMed ID: 18977099
    [Abstract] [Full Text] [Related]

  • 23. Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
    Mikucionyte G, Zamorano L, Vitkauskiene A, López-Causapé C, Juan C, Mulet X, Oliver A.
    Eur J Clin Microbiol Infect Dis; 2016 Feb 30; 35(2):195-200. PubMed ID: 26638216
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT, Khalili Y, Ghotaslou R, Yousefi S, Kafil HS, Naghili B, Sheikhalizadeh V.
    Microb Drug Resist; 2018 Mar 30; 24(2):126-135. PubMed ID: 28654368
    [Abstract] [Full Text] [Related]

  • 25. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul 30; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 26. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N, Areig Z, Al Bayssari C, Bakour S, Ali El Salabi A, Ben Gwierif S, Zorgani AA, Ben Slama K, Chouchani C, Rolain JM.
    Microb Drug Resist; 2015 Jun 30; 21(3):335-41. PubMed ID: 25587875
    [Abstract] [Full Text] [Related]

  • 27. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL, Fang YP.
    Genet Mol Res; 2015 Jun 18; 14(2):6723-32. PubMed ID: 26125881
    [Abstract] [Full Text] [Related]

  • 28. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM.
    Arch Iran Med; 2015 Feb 18; 18(2):102-8. PubMed ID: 25644798
    [Abstract] [Full Text] [Related]

  • 29. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep 18; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 30. Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.
    Telling K, Laht M, Brauer A, Remm M, Kisand V, Maimets M, Tenson T, Lutsar I.
    BMC Infect Dis; 2018 Oct 11; 18(1):513. PubMed ID: 30309321
    [Abstract] [Full Text] [Related]

  • 31. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug 11; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 32. The increasing threat of Pseudomonas aeruginosa high-risk clones.
    Oliver A, Mulet X, López-Causapé C, Juan C.
    Drug Resist Updat; 2015 Aug 11; 21-22():41-59. PubMed ID: 26304792
    [Abstract] [Full Text] [Related]

  • 33. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H, Sáenz Y, Nichols WW, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2018 Nov 11; 52(5):697-701. PubMed ID: 30081137
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
    Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N.
    Burns; 2010 Feb 11; 36(1):70-4. PubMed ID: 19524369
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
    Sefraoui I, Berrazeg M, Drissi M, Rolain JM.
    Microb Drug Resist; 2014 Apr 11; 20(2):156-61. PubMed ID: 24320688
    [Abstract] [Full Text] [Related]

  • 38. Dominance of international high-risk clones in carbapenemase-producing Pseudomonas aeruginosa: Multicentric molecular epidemiology report from India.
    Pragasam AK, Veeraraghavan B, Anandan S, Narasiman V, Sistla S, Kapil A, Mathur P, Ray P, Wattal C, Bhattacharya S, Deotale V, Subramani K, Peter JV, Hariharan TD, Ramya I, Iniyan S, Walia K, Ohri VC.
    Indian J Med Microbiol; 2018 Apr 11; 36(3):344-351. PubMed ID: 30429385
    [Abstract] [Full Text] [Related]

  • 39. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.
    Antimicrob Agents Chemother; 2017 Nov 11; 61(11):. PubMed ID: 28874376
    [Abstract] [Full Text] [Related]

  • 40. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, Nikbakht M, Khalili Y.
    J Infect Public Health; 2018 Nov 11; 11(3):364-372. PubMed ID: 28993173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.